Add Company
Join Now

Crossbow Therapeutics Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

#3033

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • Crossbow Therapeutics's estimated annual revenue is currently $5.9M per year.(i)
  • Crossbow Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Crossbow Therapeutics has 38 Employees.(i)
  • Crossbow Therapeutics grew their employee count by 81% last year.

Crossbow Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder, VP Corporate Development and OperationsReveal Email/Phone
2
CEOReveal Email/Phone
3
CEO, PresidentReveal Email/Phone
4
Co-founder, VP Corporate Development and OperationsReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
SVP BiologyReveal Email/Phone
7
VP FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Crossbow Therapeutics?

Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

81%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M380%$10M
#2
$5.5M38-7%N/A
#3
$4.4M38N/AN/A
#4
$7.5M380%N/A
#5
$4.4M3846%N/A